Sclerotherapy |
Phlebotherapy |
Obliterative action |
“Regenerative” non-obliterative action |
Highly inflammatory action |
Slightly inflammatory action |
Only clearly pathological vessels and the reticular veins connected to ectatic venules and telangiectasias are injected |
Systematic injection of all vessels visible even by means of transillumination |
Acts on the effect of the disorder |
Acts on both the cause and the effect of the disorder, i.e. on the entire perforating and superficial circulation |
|
Injecting large amounts of solution engenders risks
|
Injection of large amounts of solution is risk-free |
Efficacy proportional to the concentration of the solution injected |
Efficacy proportional to the quantity of solution injected |
The solution is not forced into the underlying vessels |
The solution is forced into the underlying vessels |
The action is two-dimensional; telangiectasias and superficial veins; in rare cases three-dimensional: main perforators. Three-dimensional action is exerted in limited areas and does not extend to the entire circulation |
Three-dimensional action extends to the entire superficial and perforating circulation |
Pre-established amounts of solution are injected into telangiectasias |
The unit of solution injected into the vessels is determined by the resistance to the plunger of the syringe |
The size of the vessels is important |
The pressure of the vessels is important |
Anti-platelet therapy is normally contraindicated |
Anti-platelet therapy is mandatory |
Sclerotherapy do not respect the anatomical and functional integrity of the circulation |
T.R.A.P. permanently restore the perforating and superficial circulation in the lower limbs |
Complications arise even if the procedure is performed correctly |
No complications if the procedure is performed correctly. |
La scleroterapia è poco efficace |
|